Guest guest Posted January 26, 2004 Report Share Posted January 26, 2004 Lupus Research Institute Reports Unprecedented Success in First Round of Grants Source: Lupus Research Institute Date: Jan 20, 2004 New York, NY, January 14, 2004 -- Eight of 11 scientists funded by the Lupus Research Institute (LRI) from 2001-2003 have been awarded more than $7 million from the National Institutes of Health (NIH) and other governmental offices to continue their novel research projects in lupus. " The primary measure of our success is the number of scientists who develop their hypotheses at the LRI and then go on to NIH grants to expand their work, " said Margaret Dowd, president of the LRI. ³The fact that 73 percent of our investigators successfully secured additional funding is a testament to our solid research strategy. The LRI emphasizes the need to remain open to radical new ideas in research and encourage high-risk, high-impact studies that stimulate new approaches to understanding, treating, and ultimately preventing lupus. " The successful research hypotheses were identified by a distinguished peer review panel, co-chaired by Lipsky, MD, scientific director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases at NIH, and Ann Marshak-Rothstein, PhD, professor of microbiology, Boston University School of Medicine. " In only three years, this talented group of researchers has been able to shed light on many of the genetic links to lupus, pinpoint the role of B-cells and certain types of white blood cells in the disease process, and provide a better understanding of how lupus attacks the brain, kidney and skin, " said Dr. Lipsky. " This type of novel research is ultimately what will move this field forward. " Researchers from Six Medical Centers The LRI scientists who have received expanded government funding are: * L. Cohen, MD, University of Pennsylvania, Philadelphia * K. Crow, MD, Hospital for Special Surgery, New York * Betty Diamond, MD, Albert Einstein College of Medicine, New York * Kotzin, MD, University of Colorado Health Sciences Center, Denver * Chandra Mohan, MD, PhD, University of Texas Southwestern Medical Center, Dallas * Chaim Putterman, MD, Albert Einstein College of Medicine, New York * Barbara J. Vilen, PhD, University of North Carolina, Chapel Hill * Werth, MD, University of Pennsylvania School of Medicine, Philadelphia ³This novel work would not have been funded without the unique granting mechanisms and model peer review process of the LRI,² said Dowd. Unraveling the Mysteries of Lupus Lupus is a chronic, systemic autoimmune disease that may attack virtually any organ or bodily system at any time. The body's immune system, which normally functions to protect against foreign invaders, becomes hyperactive, forming antibodies that attack healthy tissues and organs including the kidneys, lungs, heart, brain, blood, skin and joints. Lupus affects an estimated 1.5 million Americans and is a leading cause of kidney disease, stroke and cardiovascular disease in young women. It is chronic, yet unpredictable, with serious flares and remissions over decades. While researchers have made significant progress in recent years in understanding the genetics of lupus and how sex hormones may be involved, scientists attest that lupus remains a disease that is still not well understood. The Lupus Research Institute (LRI) maintains a broad research agenda and remains open to promising new scientific hypotheses and methodologies. Through its Novel Research Program, the LRI supports investigators nationwide in their pursuit of new approaches to improve treatment, prevent and cure lupus. The LRI currently is reviewing grant applications with particular attention to the development of early biomarkers (predictors) to assess disease activity in lupus and possible response to therapy. Currently, the LRI has awarded more than $7 million in grants, supporting 35 scientists at leading medical institutions around the country. Specific information on individual research projects can be obtained online at www.lupusresearchinstitute.org. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.